Cargando…
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone
Despite the standard of care, patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) progress to dialysis, are hospitalized for heart failure and die prematurely. Overactivation of the mineralocorticoid receptor (MR) causes inflammation and fibrosis that damages the kidney and heart. F...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130026/ https://www.ncbi.nlm.nih.gov/pubmed/33280027 http://dx.doi.org/10.1093/ndt/gfaa294 |